The burden of gastric cancer.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

18 citing papers in PubMed.

1. Association between gut microbiota and gastric cancers: a two-sample Mendelian randomization study.Frontiers in microbiology · 2024
   Article
2. Galectin-1-mediated high NCAPG expression correlates with poor prognosis in gastric cancer.Aging · 2023
   Article
3. The Hippo signaling pathway in gastric cancer.Acta biochimica et biophysica Sinica · 2023
   Review
4. The Regulation of Cyclins and Cyclin-Dependent Kinases in the Development of Gastric Cancer.International journal of molecular sciences · 2023
   Review
5. An overview of DNA methylation markers for early detection of gastric cancer: current status, challenges, and prospects.Frontiers in genetics · 2023
   Review
6. Falling Trend in the Epidemiology of Gastric Cancer in Mississippi From 2003 to 2019: What Mississippi Got Right.Cureus · 2022
   Article
7. Identification of hub pathways and drug candidates in gastric cancer through systems biology.Scientific reports · 2022
   Article
8. Impact of Selected Serum Factors on Metastatic Potential of Gastric Cancer Cells.Diagnostics (Basel, Switzerland) · 2022
   Article
9. Ureteral metastasis from gastric cancer after two years of subtotal gastrectomy: a case report.Radiology case reports · 2022
   Article
10. ASF1b is a novel prognostic predictor associated with cell cycle signaling pathway in gastric cancer.Journal of Cancer · 2022
    Article
11. Novel approach to identify putative Epstein-Barr-virus microRNAs regulating host cell genes with relevance in tumor biology and immunology.Oncoimmunology · 2022
    Article
12. Epstein-Barr Virus-Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies.Cancers · 2021
    Review
13. Efficacy of circulating microRNA-130b and blood routine parameters in the early diagnosis of gastric cancer.Oncology letters · 2021
    Article
14. hsa_circ_0060975 is highly expressed and predicts a poor prognosis in gastric cancer.Oncology letters · 2021
    Article
15. Dichotomous role of microtubule associated protein tau as a biomarker of response to and a target for increasing efficacy of taxane treatment in cancers of epithelial origin.Pharmacological research · 2021
    Review
16. LncRNA HOXA-AS3 promotes gastric cancer progression by regulating miR-29a-3p/LTβR and activating NF-κB signaling.Cancer cell international · 2021
    Article
17. 3,3'-Diindolylmethane Promotes Gastric Cancer ProgressionFrontiers in oncology · 2021
    Article
18. Centromere Protein I (CENP-I) Is Upregulated in Gastric Cancer, Predicts Poor Prognosis, and Promotes Tumor Cell Proliferation and Migration.Technology in cancer research & treatment
    Article

Corrections and comments

• Comment on
  Inpatient burden of gastric cancer in the United States.2019

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.